Atwood & Palmer’s bluebird bio BLUE Stock Holding History

Atwood & Palmer’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-7	Closed	-$8K	–	401
2015 Q3	$8K	Buy	+7	New	+$12.8K	﹤0.01%	349

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Atwood & Palmer's BLUE Position: Q4 2015 in Review

Atwood & Palmer sold out of bluebird bio (BLUE) in Q4 2015, closing a stake of 7 shares — an estimated $8K sold.

Atwood & Palmer first reported a position in BLUE in Q3 2015 and held it in 1 quarter. The position peaked at $8K in Q3 2015. 193 funds tracked by Wall St. Rank hold BLUE as of Q4 2015.

Atwood & Palmer reported no remaining bluebird bio position as of Q4 2015 after selling out during the quarter.
Atwood & Palmer sold 7 bluebird bio shares in Q4 2015, an estimated $8K.
Atwood & Palmer first reported a position in bluebird bio in Q3 2015 and held it in 1 quarter.
Atwood & Palmer's bluebird bio position peaked at $8K in Q3 2015.
193 funds tracked by Wall St. Rank held bluebird bio as of Q4 2015.

Based on Atwood & Palmer's 13F filing for Q4 2015, filed 28 Jan 2016.